| Outcome Measures: |
Primary: Change From Baseline In A1C at Week 26, A1C is measured as percent. The change from baseline is the Week 26 A1C percent minus the Week 0 A1C percent. Laboratory measurements were performed after an overnight fast ≥10 hours in duration. Data presented exclude data following the initiation of rescue therapy., Baseline and Week 26|Percentage of Participants Experiencing An Adverse Event (AE), An AE is defined as any untoward medical occurrence in a patient or clinical investigation participant administered a pharmaceutical product and which does not necessarily have to have a causal relationship with this treatment. Data presented include data following the initiation of rescue therapy., Up to 54 weeks (including 2 weeks following last dose)|Percentage of Participants Discontinuing Study Treatment Due to an AE, An AE is defined as any untoward medical occurrence in a patient or clinical investigation participant administered a pharmaceutical product and which does not necessarily have to have a causal relationship with this treatment. Data presented include data following the initiation of rescue therapy., Up to 52 weeks | Secondary: Change From Baseline in FPG at Week 26, The change from baseline is the Week 26 FPG minus the Week 0 FPG. Laboratory measurements were performed after an overnight fast ≥10 hours in duration. Data presented exclude data following the initiation of glycemic rescue therapy., Baseline and Week 26|Change From Baseline in Body Weight at Week 26, The change from baseline is the Week 26 body weight minus the Week 0 body weight. Data presented exclude data following the initiation of rescue therapy., Baseline and Week 26|Percentage of Participants With A1C <7% (<53 mmol/Mol) at Week 26, A1C is measured as percent. Laboratory measurements were performed after an overnight fast ≥10 hours in duration. Data presented exclude data following the initiation of rescue therapy., Week 26|Baseline 2-hour Post-prandial Glucose (2-hr PPG) Level, Laboratory measurements were performed 120 minutes following the start of the administration of the meal for the Mixed Meal Tolerance Test (MMTT). Change from baseline in 2-hr PPG level at Week 26 data are presented in the following outcome measure., Baseline|Change From Baseline in 2-hr PPG at Week 26, The change from baseline is the Week 26 2-hr PPG minus the Week 0 2-hr PPG. Laboratory measurements were performed 120 minutes following the start of the administration of the meal for the MMTT. Data presented exclude data following the initiation of rescue therapy., Baseline and Week 26|Baseline Sitting Systolic Blood Pressure (SBP), Sitting blood pressure was measured in triplicate and the average of the measurements taken at a single assessment time was analyzed. Change from baseline in SBP at Week 26 data are presented in the following outcome measure., Baseline|Change From Baseline in SBP at Week 26, The change from baseline is the Week 26 SBP minus the Week 0 SBP. Sitting blood pressure was measured in triplicate and the average of the measurements taken at a single assessment time was analyzed. Data presented exclude data following the initiation of rescue therapy., Baseline and Week 26|Baseline Sitting Diastolic Blood Pressure (DBP), Sitting blood pressure was measured in triplicate and the average of the measurements taken at a single assessment time was analyzed. Change from baseline in DBP at Week 26 data are presented in the following outcome measure., Baseline|Change From Baseline in DBP at Week 26, The change from baseline is the Week 26 DBP minus the Week 0 DBP. Sitting blood pressure was measured in triplicate and the average of the measurements taken at a single assessment time was analyzed. Data presented exclude data following the initiation of rescue therapy., Baseline and Week 26
|
